CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 129 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $3,000 | -70.0% | 15,001 | -29.5% | 0.00% | -100.0% |
Q3 2018 | $10,000 | -16.7% | 21,293 | -10.4% | 0.00% | 0.0% |
Q2 2018 | $12,000 | -55.6% | 23,761 | +106.3% | 0.00% | 0.0% |
Q1 2018 | $27,000 | -73.0% | 11,516 | -67.1% | 0.00% | -80.0% |
Q3 2017 | $100,000 | -67.0% | 34,975 | +191.0% | 0.01% | -81.5% |
Q2 2015 | $303,000 | – | 12,020 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KLP Enterprises, LLC | 6,865,006 | $3,457,000 | 100.00% |
Meditor Group Ltd | 6,312,700 | $3,179,000 | 0.62% |
TSP Capital Management Group, LLC | 1,328,207 | $669,000 | 0.34% |
GREAT POINT PARTNERS LLC | 804,483 | $405,000 | 0.06% |
Telemetry Investments, L.L.C. | 252,300 | $127,000 | 0.05% |
Centiva Capital, LP | 187,749 | $95,000 | 0.02% |
Benchmark Capital Advisors | 54,400 | $27,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 639,800 | $322,000 | 0.02% |
BOENNING & SCATTERGOOD, INC. | 79,400 | $40,000 | 0.01% |
LMR Partners LLP | 408,846 | $206,000 | 0.01% |